These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22615276)

  • 1. Novel antibiotics targeting respiratory ATP synthesis in Gram-positive pathogenic bacteria.
    Balemans W; Vranckx L; Lounis N; Pop O; Guillemont J; Vergauwen K; Mol S; Gilissen R; Motte M; Lançois D; De Bolle M; Bonroy K; Lill H; Andries K; Bald D; Koul A
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4131-9. PubMed ID: 22615276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the ATP Synthase Eliminates the Intrinsic Resistance of
    Vestergaard M; Nøhr-Meldgaard K; Bojer MS; Krogsgård Nielsen C; Meyer RL; Slavetinsky C; Peschel A; Ingmer H
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874470
    [No Abstract]   [Full Text] [Related]  

  • 3. New mutations in the mycobacterial ATP synthase: new insights into the binding of the diarylquinoline TMC207 to the ATP synthase C-ring structure.
    Segala E; Sougakoff W; Nevejans-Chauffour A; Jarlier V; Petrella S
    Antimicrob Agents Chemother; 2012 May; 56(5):2326-34. PubMed ID: 22354303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcal Bacterial Persister Cells, Biofilms, and Intracellular Infection Are Disrupted by JD1, a Membrane-Damaging Small Molecule.
    Dombach JL; Quintana JLJ; Detweiler CS
    mBio; 2021 Oct; 12(5):e0180121. PubMed ID: 34634935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor.
    Huitric E; Verhasselt P; Andries K; Hoffner SE
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4202-4. PubMed ID: 17709466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor.
    Huitric E; Verhasselt P; Koul A; Andries K; Hoffner S; Andersson DI
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1022-8. PubMed ID: 20038615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of TMC207 and its N-desmethyl metabolite in a murine model of tuberculosis.
    Rouan MC; Lounis N; Gevers T; Dillen L; Gilissen R; Raoof A; Andries K
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1444-51. PubMed ID: 22155815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMC207: the first compound of a new class of potent anti-tuberculosis drugs.
    Matteelli A; Carvalho AC; Dooley KE; Kritski A
    Future Microbiol; 2010 Jun; 5(6):849-58. PubMed ID: 20521931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diarylquinolines, synthesis pathways and quantitative structure--activity relationship studies leading to the discovery of TMC207.
    Guillemont J; Meyer C; Poncelet A; Bourdrez X; Andries K
    Future Med Chem; 2011 Sep; 3(11):1345-60. PubMed ID: 21879841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthra[1,2-
    Zvarych V; Stasevych M; Novikov V; Rusanov E; Vovk M; Szweda P; Grecka K; Milewski S
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31847306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP Synthase, an Emerging Target in TB Drug Discovery: Review of SAR and Clinical Pharmacology of Diarylquinoline Inhibitors.
    Dhulap A; Banerjee P
    Curr Drug Targets; 2021; 22(11):1207-1221. PubMed ID: 33480344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diarylquinolines target subunit c of mycobacterial ATP synthase.
    Koul A; Dendouga N; Vergauwen K; Molenberghs B; Vranckx L; Willebrords R; Ristic Z; Lill H; Dorange I; Guillemont J; Bald D; Andries K
    Nat Chem Biol; 2007 Jun; 3(6):323-4. PubMed ID: 17496888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound.
    Butler MM; Lamarr WA; Foster KA; Barnes MH; Skow DJ; Lyden PT; Kustigian LM; Zhi C; Brown NC; Wright GE; Bowlin TL
    Antimicrob Agents Chemother; 2007 Jan; 51(1):119-27. PubMed ID: 17074800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the interaction of the diarylquinoline TMC207 with its target mycobacterial ATP synthase.
    Haagsma AC; Podasca I; Koul A; Andries K; Guillemont J; Lill H; Bald D
    PLoS One; 2011; 6(8):e23575. PubMed ID: 21858172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crizotinib Shows Antibacterial Activity against Gram-Positive Bacteria by Reducing ATP Production and Targeting the CTP Synthase PyrG.
    Zheng YD; Zhong T; Wu H; Li N; Fang Z; Cao L; Yin XF; He QY; Ge R; Sun X
    Microbiol Spectr; 2022 Jun; 10(3):e0088422. PubMed ID: 35674439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Methionyl-tRNA Synthetase Inhibitors as Antibiotics for Gram-Positive Bacterial Infections.
    Faghih O; Zhang Z; Ranade RM; Gillespie JR; Creason SA; Huang W; Shibata S; Barros-Álvarez X; Verlinde CLMJ; Hol WGJ; Fan E; Buckner FS
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP Synthase Inhibitors as Anti-tubercular Agents: QSAR Studies in Novel Substituted Quinolines.
    Saxena AK; Alam M
    Curr Top Med Chem; 2020; 20(29):2723-2734. PubMed ID: 32885753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial Effect of Carbosilane Metallodendrimers in Planktonic Cells of Gram-Positive and Gram-Negative Bacteria and
    Llamazares C; Sanz Del Olmo N; Ortega P; Gómez R; Soliveri J; de la Mata FJ; García-Gallego S; Copa-Patiño JL
    Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31450779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.
    Worley MV; Estrada SJ
    Pharmacotherapy; 2014 Nov; 34(11):1187-97. PubMed ID: 25203970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis.
    Koul A; Vranckx L; Dendouga N; Balemans W; Van den Wyngaert I; Vergauwen K; Göhlmann HWH; Willebrords R; Poncelet A; Guillemont J; Bald D; Andries K
    J Biol Chem; 2008 Sep; 283(37):25273-25280. PubMed ID: 18625705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.